España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
PILL
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.40
0.22
2.69%
At close: -
$8.02
-0.38
-4.52%
After Hours: 8:53 AM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Direxion Daily Pharmaceutical & Medical Bull 3X Shares (ARCA:PILL)
Direxion Daily Pharmaceutical & Medical Bull 3X Shares (ARCA: PILL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 15, 2021
3 Pharmaceutical ETFs That Could Be Due For A Rebound
Mark Putrino
Thursday, October 15, 2020
Heading Into The Election, Traders Are Still Betting On Tech
Direxion
Tuesday, May 19, 2020
In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs
Direxion
Sunday, February 23, 2020
~150 Prescription Drugs, Including Antibiotics, Generics, Some Branded Drugs without Alternatives Face Shortages Due to Coronavirus
Charles Gross
Monday, February 10, 2020
3 Leveraged Healthcare ETFs Soaring This Month
ETF Professor
Thursday, January 16, 2020
Expert: 'I've had far fewer defensive conversations than I would have expected' About The Market
Jaycee Tenn
Tuesday, July 23, 2019
With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF
ETF Professor
Tuesday, February 26, 2019
It Could Be Time For This Pharma ETF
ETF Professor
Friday, February 01, 2019
Pharma Catches Another Case Of M&A Fever
Chris Dier-Scalise
Friday, July 27, 2018
Having Fun With Pharma ETFs
ETF Professor
Wednesday, November 29, 2017
A Lazarus Act For This Pharma ETF
Benzinga
CUREs For The Ordinary December Trade
Benzinga